Clinical Trial Update: Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial explores cyclosporine A combined with low-steroid treatment for COVID-19 pneumonia in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Conditions: COVID 19 Pneumonia | Phase 1, Phase 2 | Status: UNKNOWN